Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Goebell

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
European Urology|December 3, 2019
Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420-33: A Statement from the International Bladder Cancer NetworkStephen B Williams, Peter C Black, Lars Dyrskjøt, et al.
Anticancer Research|July 1, 2015
Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial CarcinomaDanijel Sikic, Sven Wach, Helge Taubert, et al.
Cancers|November 26, 2022
The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment LandscapeChristian Doehn, Martin Bögemann, Viktor Grünwald, et al.
International Journal of Clinical and Experimental Pathology|October 18, 2013
Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer riskAnja Rogler, Sabine Hoja, Eileen Socher, et al.
The British Journal of Nutrition|November 10, 2022
Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN studyBernd J Schmitz-Dräger, Ekkehardt Bismarck, Dorothee Grammenos, et al.
International Journal of Cancer|August 2, 2020
First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trialMichael Staehler, Andrej Panic, Peter J Goebell, et al.
Oncology Research and Treatment|January 21, 2019
Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO StudyPeter J Goebell, Edwin Hermann, Ulrich Kube, et al.
Clinical Genitourinary Cancer|August 1, 2018
Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-RegistryPeter J Goebell, Michael Staehler, Lothar Müller, et al.
Urologic Oncology|January 14, 2023
Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updatesPeter J Goebell, Ashish M Kamat, Peter C Black, et al.
Journal of Clinical Medicine|August 12, 2022
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA TrialKatja Schlichtig, Lisa Cuba, Pauline Dürr, et al.
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
European Urology|December 3, 2019
Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420-33: A Statement from the International Bladder Cancer NetworkStephen B Williams, Peter C Black, Lars Dyrskjøt, et al.
Anticancer Research|July 1, 2015
Female Gender Is an Age-dependent Negative Prognostic Factor for Patients with Upper Tract Urothelial CarcinomaDanijel Sikic, Sven Wach, Helge Taubert, et al.
Cancers|November 26, 2022
The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment LandscapeChristian Doehn, Martin Bögemann, Viktor Grünwald, et al.
International Journal of Clinical and Experimental Pathology|October 18, 2013
Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer riskAnja Rogler, Sabine Hoja, Eileen Socher, et al.
The British Journal of Nutrition|November 10, 2022
Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN studyBernd J Schmitz-Dräger, Ekkehardt Bismarck, Dorothee Grammenos, et al.
International Journal of Cancer|August 2, 2020
First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trialMichael Staehler, Andrej Panic, Peter J Goebell, et al.
Oncology Research and Treatment|January 21, 2019
Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO StudyPeter J Goebell, Edwin Hermann, Ulrich Kube, et al.
Clinical Genitourinary Cancer|August 1, 2018
Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma - Analyses From the German Clinical RCC-RegistryPeter J Goebell, Michael Staehler, Lothar Müller, et al.
Urologic Oncology|January 14, 2023
Editorial: Cutting edge basic and clinical bladder cancer research - the IBCN updatesPeter J Goebell, Ashish M Kamat, Peter C Black, et al.
Journal of Clinical Medicine|August 12, 2022
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA TrialKatja Schlichtig, Lisa Cuba, Pauline Dürr, et al.
Pageof 11